Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project

BACKGROUND: Biomarkers such as cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI) have predictive value for progression to dementia in patients with mild cognitive impairment (MCI). The pre-dementia stage takes far longer, and the interpretation of biomarker findings is particular releva...

Descripción completa

Detalles Bibliográficos
Autores principales: van Maurik, Ingrid S., Slot, Rosalinde E. R., Verfaillie, Sander C. J., Zwan, Marissa D., Bouwman, Femke H., Prins, Niels D., Teunissen, Charlotte E., Scheltens, Philip, Barkhof, Frederik, Wattjes, Mike P., Molinuevo, Jose Luis, Rami, Lorena, Wolfsgruber, Steffen, Peters, Oliver, Jessen, Frank, Berkhof, Johannes, van der Flier, Wiesje M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466790/
https://www.ncbi.nlm.nih.gov/pubmed/30987684
http://dx.doi.org/10.1186/s13195-019-0487-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466790/
https://www.ncbi.nlm.nih.gov/pubmed/30987684
http://dx.doi.org/10.1186/s13195-019-0487-y

Ejemplares similares